Gland Pharma Limited (NSE:GLAND)
India · Delayed Price · Currency is INR 3,315.00
+51.10 (1.57%)
Nov 12, 2026, 3:29 PM IST
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 546.86 billion as of November 12, 2026. It is the 3,286th most valuable company in the world and the 199th biggest in India. Its market cap has increased by 79.30% in one year.
Market Cap
546.86B
Enterprise Value
514.96B
Revenue
70.61B
Global Rank
Country Rank
#199 India
PE Ratio
44.27
ChartMarket Cap Chart
Since November 20, 2020, Gland Pharma's market cap has increased from 297.10B to 546.86B, an increase of 84.07%. That is a compound annual growth rate of 10.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 545.83B | 92.39% |
| Dec 31, 2025 | 283.71B | -3.22% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zydus Lifesciences | 1.20T |
| Cipla | 1.14T |
| Mankind Pharma | 1.09T |
| Aurobindo Pharma | 1.04T |
| Glenmark Pharmaceuticals | 750.65B |
| Alkem Laboratories | 633.93B |
| Ipca Laboratories | 483.31B |
| Emcure Pharmaceuticals | 442.79B |